A possibility supported by experimental data from BioGRID could be that the Myc‐fibronectin interaction would be indirect, passing through the von Hippel–Lindau disease tumour suppressor (VHL), which is in the cytoplasm, membrane and nucleus, simultaneously. This evidence concerns the gene MYC and von Hippel-Lindau disease.